Predicting utility for joint health states: a general framework and a new nonparametric estimator
- PMID: 20643911
- DOI: 10.1177/0272989X10374508
Predicting utility for joint health states: a general framework and a new nonparametric estimator
Abstract
Measuring utility is important in clinical decision making and cost-effectiveness analysis because utilities are often used to compute quality-adjusted life expectancy, a metric used in measuring the effectiveness of health care programs and medical interventions. Predicting utility for joint health states has become an increasingly valuable research topic because of the aging of the population and the increasing prevalence of comorbidities. Although multiplicative, minimum, and additive estimators are commonly used in practice, research has shown that they are all biased. In this study, the authors propose a general framework for predicting utility for joint health states. This framework includes these 3 nonparametric estimators as special cases. A new simple nonparametric estimator, the adjusted decrement estimator, [U(ij) = U(min) - U(min) (1 - U(i) )(1 - U(j) )], is introduced under the proposed framework. When applied to 2 independent data sources, the new nonparametric estimator not only generated unbiased prediction of utilities for joint health states but also had the least root mean squared error and highest concordance when compared with other nonparametric and parametric estimators. Further research and validation of this new estimator are needed.
Similar articles
-
Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories.Med Decis Making. 2008 Jan-Feb;28(1):102-12. doi: 10.1177/0272989X07309639. Epub 2007 Dec 5. Med Decis Making. 2008. PMID: 18057188
-
A linear index for predicting joint health-states utilities from single health-states utilities.Health Econ. 2009 Apr;18(4):403-19. doi: 10.1002/hec.1373. Health Econ. 2009. PMID: 18773392
-
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127. Pediatrics. 2005. PMID: 15867026 Review.
-
Utilities should not be multiplied: evidence from the preference-based scores in the United States.Med Care. 2008 Sep;46(9):984-90. doi: 10.1097/MLR.0b013e3181791a9c. Med Care. 2008. PMID: 18725854
-
Comparative effectiveness.Curr Opin Ophthalmol. 2009 May;20(3):147-50. doi: 10.1097/ICU.0b013e32832adf0c. Curr Opin Ophthalmol. 2009. PMID: 19387344 Review.
Cited by
-
Economic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited Setting.Biomed Res Int. 2018 Aug 2;2018:9282646. doi: 10.1155/2018/9282646. eCollection 2018. Biomed Res Int. 2018. PMID: 30155484 Free PMC article.
-
Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China.Adv Ther. 2017 Feb;34(2):466-480. doi: 10.1007/s12325-016-0460-0. Epub 2016 Dec 20. Adv Ther. 2017. PMID: 28000167 Free PMC article.
-
Examining the relationship between health-related quality of life and increasing numbers of diagnoses.Qual Life Res. 2015 Dec;24(12):2823-32. doi: 10.1007/s11136-015-1026-3. Epub 2015 Jun 12. Qual Life Res. 2015. PMID: 26068730 Free PMC article.
-
Sourcing quality-of-life weights obtained from previous studies: theory and reality in Korea.Patient. 2014;7(2):141-50. doi: 10.1007/s40271-014-0049-0. Patient. 2014. PMID: 24578251
-
Comparative quality-adjusted survival analysis between radiation therapy alone and radiation with androgen deprivation therapy in patients with locally advanced prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 85-31 with novel decision analysis methods.Prostate Int. 2018 Dec;6(4):140-144. doi: 10.1016/j.prnil.2018.01.002. Epub 2018 Feb 2. Prostate Int. 2018. PMID: 30505816 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources